389 related articles for article (PubMed ID: 32435808)
1. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
[TBL] [Abstract][Full Text] [Related]
2. Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection.
Krotulski AJ; Mohr ALA; Logan BK
J Anal Toxicol; 2020 Apr; 44(3):207-217. PubMed ID: 31909808
[TBL] [Abstract][Full Text] [Related]
3. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
[TBL] [Abstract][Full Text] [Related]
4. [Determination of four amide synthetic cannabinoid isomers by ultra-high performance liquid chromatography-high resolution mass spectrometry].
Tang R; Wang J; Xiao T; Qin S; Jie Z; Zhang A
Se Pu; 2024 Jan; 42(1):84-91. PubMed ID: 38197209
[TBL] [Abstract][Full Text] [Related]
5. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids.
Gatch MB; Forster MJ
Neurotoxicology; 2019 Jan; 70():72-79. PubMed ID: 30439379
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and
Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
[TBL] [Abstract][Full Text] [Related]
9. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
[TBL] [Abstract][Full Text] [Related]
10. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
[TBL] [Abstract][Full Text] [Related]
11. Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA-parent compounds and metabolite identification in blood, urine and cerebrospinal fluid.
Tokarczyk B; Jurczyk A; Krupińska J; Adamowicz P
Forensic Sci Med Pathol; 2022 Dec; 18(4):393-402. PubMed ID: 35699867
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of the synthetic cannabinoid, 5F-MDMB-PICA, in male rats.
Krotulski AJ; Garibay N; Walther D; Walton SE; Mohr ALA; Logan BK; Baumann MH
Neuropharmacology; 2021 Nov; 199():108800. PubMed ID: 34547333
[TBL] [Abstract][Full Text] [Related]
13. The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA.
Krotulski AJ; Cannaert A; Stove C; Logan BK
Drug Test Anal; 2021 Feb; 13(2):427-438. PubMed ID: 32997377
[TBL] [Abstract][Full Text] [Related]
14. Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors.
Cabanlong CV; Russell LN; Fantegrossi WE; Prather PL
Toxicol Sci; 2022 Apr; 187(1):175-185. PubMed ID: 35201352
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Synthetic Cannabinoid Deaths in State of Florida Prisoners.
Hvozdovich JA; Chronister CW; Logan BK; Goldberger BA
J Anal Toxicol; 2020 Apr; 44(3):298-300. PubMed ID: 31776572
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.
Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M
ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060
[TBL] [Abstract][Full Text] [Related]
17. 4F-MDMB-BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework.
Krotulski AJ; Mohr ALA; Kacinko SL; Fogarty MF; Shuda SA; Diamond FX; Kinney WA; Menendez MJ; Logan BK
J Forensic Sci; 2019 Sep; 64(5):1451-1461. PubMed ID: 31260580
[TBL] [Abstract][Full Text] [Related]
18. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Apr; 82(67):17119-24. PubMed ID: 28425681
[TBL] [Abstract][Full Text] [Related]
19. Focusing on the 5F-MDMB-PICA, 4F-MDMB-BICA synthetic cannabinoids and their primary metabolites in analytical and pharmacological aspects.
Dvorácskó S; Körmöczi T; Sija É; Bende B; Weiczner R; Varga T; Ilisz I; Institóris L; Kereszty ÉM; Tömböly C; Berkecz R
Toxicol Appl Pharmacol; 2023 Jul; 470():116548. PubMed ID: 37182749
[TBL] [Abstract][Full Text] [Related]
20. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018.
Liu C; Jia W; Hua Z; Qian Z
Drug Test Anal; 2017 Aug; 9(8):1251-1261. PubMed ID: 28063270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
